Transversal, you make some good points re relative valuation. I think TBR is the better bet at these prices. One problem though is that the management is similar. If they were contemplating a massively dilutive deal for RND, it is quite possible one will come ut of left field for TBR as well.
One hope is that NST will take both companies out at a premium but not sure that they would accept even a generous offer.
- Forums
- ASX - By Stock
- not happy jan
Transversal, you make some good points re relative valuation. I...
Featured News
Add TBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.90 |
Change
0.020(0.41%) |
Mkt cap ! $256.0M |
Open | High | Low | Value | Volume |
$4.86 | $4.90 | $4.86 | $46.88K | 9.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9835 | $4.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.92 | 112 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10520 | 4.900 |
2 | 7525 | 4.880 |
1 | 511 | 4.870 |
2 | 4783 | 4.860 |
1 | 782 | 4.850 |
Price($) | Vol. | No. |
---|---|---|
4.920 | 112 | 4 |
4.930 | 2029 | 2 |
4.960 | 1521 | 1 |
4.980 | 1962 | 1 |
5.000 | 1000 | 1 |
Last trade - 15.04pm 13/11/2024 (20 minute delay) ? |
Featured News
TBR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online